Grünenthal is a global leader in pain management. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Company

A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.

... We are Grünenthal

Grünenthal’s product portfolio, brands, ingredients and indication range.

... Products

A mix of strong entrepreneurial spirit, close collaboration, and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Partnering

In view of our vision of a World Free of Pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

Explore our media section and access a range of materials relating to our company.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2019 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Media - Our stories

Explore our recent stories to see what drives us

10 February 2022

Meet the next generation of pain researchers

Pain Researchers

Since 2004 the European Pain Federation EFIC® and Grünenthal have facilitated the projects of scientists in the field of pain research through the European Pain Federation EFIC® - Grünenthal grant (E-G-G). This biennial grant supports innovative pain research projects by early-career scientists and physicians from any member country of the European Pain Federation EFIC.

Pain has an immense burden on the population, with one in five people in Europe living with chronic pain. Not only does it have a negative impact on quality of life, it creates a substantial economic and social burden. This Grant represents Grünenthal’s continued commitment to making life-changing pain research possible and ultimately improving the lives of people living with pain.

E-G-G received 79 applications. In a two-step evaluation, seven selected reviewers and four members of the EFIC® Research Committee Working Group on Grants and Prizes selected 5 research projects for funding:

The E-G-G winners 2022

EGG EFIC Grünenthal grant winners 2022

The winners will be officially recognised during the opening ceremony of the 12th Congress of the European Pain Federation EFIC® in Dublin, Ireland, from 27 to 30 April 2022.

For more information visit www.e-g-g.info.

Research, Science